New Adjuvant Treatment of Locally Advanced Resectable Gastric Cancer With Carelizumab and XELOX
Clinical trial NCT05715632 · UNKNOWN
Trial details
- NCT number
- NCT05715632
- Sponsor
- Tang-Du Hospital
- Status
- UNKNOWN
- Phase
- Not Applicable
- Study type
- INTERVENTIONAL
- Start date
- 2023-02-01
- Primary completion
- 2024-03-01
- Enrollment
- 46
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.